Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) Return on Sales (2024 - 2025)

Historic Return on Sales for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to 1075.0%.

  • Connect Biopharma Holdings' Return on Sales fell 10644400.0% to 1075.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 64.67%, marking a year-over-year decrease of 591500.0%. This contributed to the annual value of 0.6% for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Connect Biopharma Holdings' Return on Sales stood at 1075.0%, which was down 10644400.0% from 268.73% recorded in Q2 2025.
  • Over the past 5 years, Connect Biopharma Holdings' Return on Sales peaked at 8.98% during Q1 2025, and registered a low of 1075.0% during Q3 2025.